A Phase III Clinical Study Evaluating the Efficacy Of FST-201 Otic Suspension (Foresight Biotherapeutics, Inc.) Vs. Ciprodex Otic Suspension (Alcon Laboratories, Inc.) in Subjects With Acute Otitis Externa.

Trial Profile

A Phase III Clinical Study Evaluating the Efficacy Of FST-201 Otic Suspension (Foresight Biotherapeutics, Inc.) Vs. Ciprodex Otic Suspension (Alcon Laboratories, Inc.) in Subjects With Acute Otitis Externa.

Completed
Phase of Trial: Phase III

Latest Information Update: 05 Oct 2015

At a glance

  • Drugs Povidone iodine/dexamethasone (Primary) ; Ciprofloxacin/dexamethasone
  • Indications Otitis externa
  • Focus Registrational; Therapeutic Use
  • Sponsors Shire
  • Most Recent Events

    • 13 Oct 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 27 Aug 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top